CLEVELAND—Tersus Pharmaceuticals received a Compositions and Methods U.S. Patent for its branded purified omega-7 fatty acid blend, Provinal.
Provinal is a 30-percent-plus purified concentration of palmitoleic acid and now holds U.S. patent No. 8,703,818 (comprising C16:1n7-palmitoleate or derivatives).
“Feedback from the health care industry and reaction to recent studies (on Provinal) has been extremely positive and encouraging," said Lochlainn O’Haimhirgin, president of Tersus Pharmaceuticals LLC.
Provinal contains a 50-percent concentration of palmitoleic acid, an omega-7 monounsaturated fatty acid. Palmitoleic acid has been shown to support healthy cholesterol and C-reactive protein levels (a marker for inflammation in the body), and has a beneficial effect on other metabolic variables. The hsCRP test is a highly sensitive quantification of CRP, an acute-phase protein released into the blood by the liver during inflammation, which has been associated with the presence of heart disease.
For more information on omega-7 and Provinal, watch the INSIDER Partner Series Webinar.